NCT05546372

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma: a Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 98 (estimated)
• Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A multicentre, parallel group, open label, randomized controlled trial comparing endobiliary RFA prior to metal stent placement with stent placement only in patients with inoperable perihilar cholangiocarcinoma.

Conditions

• Perihilar Cholangiocarcinoma

Interventions

Type	Name	Description
DEVICE	Endobiliary radiofrequency ablation (eRFA)	Intraductal radiofrequency ablation of tumor prior to stent placement
DEVICE	uncovered self-expanding metal stent (uSEMS)	Intraductal placement of uncovered metal stent

Timeline

• Start date: 2023-11-09
• Primary completion: 2026-03-31
• Completion: 2026-03-31
• First posted: 2022-09-19
• Last updated: 2022-10-27

Locations

1 site across 1 country: Netherlands